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Abstract
Background
Trypanosomatid parasites represent a major health issue affecting hundreds of million peo-
ple worldwide, with clinical treatments that are partially effective and/or very toxic. They are
responsible for serious human and plant diseases including Trypanosoma cruzi (Chagas
disease), Trypanosoma brucei (Sleeping sickness), Leishmania spp. (Leishmaniasis), and
Phytomonas spp. (phytoparasites). Both, animals and trypanosomatids lack the biosyn-
thetic riboflavin (vitamin B2) pathway, the vital precursor of flavin mononucleotide (FMN)
and flavin adenine dinucleotide (FAD) cofactors. While metazoans obtain riboflavin from the
diet through RFVT/SLC52 transporters, the riboflavin transport mechanisms in trypanoso-
matids still remain unknown.
Methodology/Principal findings
Here, we show that riboflavin is imported with high affinity in Trypanosoma cruzi, Trypanosoma
brucei, Leishmania (Leishmania) mexicana, Crithidia fasciculata and Phytomonas Jma using
radiolabeled riboflavin transport assays. The vitamin is incorporated through a saturable carrier-
mediated process. Effective competitive uptake occurs with riboflavin analogs roseoflavin, lumi-
flavin and lumichrome, and co-factor derivatives FMN and FAD. Moreover, important biological
processes evaluated in T. cruzi (i.e. proliferation, metacyclogenesis and amastigote replication)
are dependent on riboflavin availability. In addition, the riboflavin competitive analogs were found
to interfere with parasite physiology on riboflavin-dependent processes. By means of bioinfor-
matics analyses we identified a novel family of riboflavin transporters (RibJ) in trypanosomatids.
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Two RibJ members, TcRibJ and TbRibJ from T. cruzi and T. brucei respectively, were function-
ally characterized using homologous and/or heterologous expression systems.
Conclusions/Significance
The RibJ family represents the first riboflavin transporters found in protists and the third
eukaryotic family known to date. The essentiality of riboflavin for trypanosomatids, and the
structural/biochemical differences that RFVT/SLC52 and RibJ present, make the riboflavin
transporter -and its downstream metabolism- a potential trypanocidal drug target.
Author summary
In this work, we show that riboflavin plays a key role in the trypanosomatid life cycles and
describe a novel family of riboflavin transporters (RibJ) with uptake function. Despite the
vital importance of riboflavin for all living cells, RibJ are the first transporters described in
protists. We functionally characterized the T. cruzi and T. brucei RibJ members and the
effect of riboflavin analogs on parasite physiology. The structural and biochemical differ-
ences presented between human transporters and RibJ members make riboflavin trans-
port and downstream metabolism, attractive and potential trypanosomatid targets.
Introduction
Trypanosomatida (class Kinetoplastea) is a major parasitic lineage which infects a high variety
of hosts, with insects being their principal vectors. Some trypanosomatids cause common par-
asitic diseases in humans including Chagas disease (or American Trypanosomiasis) caused by
Trypanosoma cruzi, sleeping sickness (or Human African Trypanosomiasis) caused by Trypa-
nosoma brucei and different manifestations of leishmaniasis (cutaneous, mucocutaneous and
visceral leishmaniasis) caused by Leishmania spp., with major health impacts around the
world [1–3]. Trypanosomatids undergo complex life cycles, involving proliferative and infec-
tive stages and intra- or extracellular cycles [1,4–7]. Current clinical treatments are based on
drugs generally effective for early-infections and with many associated toxic side effects. Treat-
ments are usually long-lasting and may be difficult to administer; frequently parasites develop
resistance against the drugs [8–10]. Hence, there is a clear need to find new therapies against
these diseases.
Riboflavin (vitamin B2) is an essential micronutrient for all living cells. It is the precursor of
flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), cofactors of numerous
flavoenzymes playing a pivotal role in redox centers [11]. Metazoa and some microorganisms
lack the biosynthetic pathway for riboflavin, obtaining it from the environment through spe-
cific transporters [12–14]. In contrast, plants, fungi and most prokaryotes synthesize riboflavin
de novo [15]. Noteworthy, some of the prototrophic microorganisms that synthesize this vita-
min also present exporting and/or importing mechanisms [16–21]. Strikingly, flavin biosyn-
thesis and transport also play a role in microbial infection processes from pathogens and
symbionts, as well as in tumorigenesis in some cancer types [19,22–28].
In trypanosomatids, flavoenzymes play important physiological roles including the trypa-
nothione reductase (a FAD disulphide oxidoreductase), the main component of the antioxi-
dant system in trypanosomatids [29]. Similar to Metazoa, T. cruzi lacks the enzymes involved
in de novo riboflavin biosynthesis but its genome codes for the enzymes that convert riboflavin
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into FMN (riboflavin kinase, EC 2.7.1.26) and the latter into FAD (FAD synthetase, EC 2.7.7.2)
[30]. This seems to be a general rule for trypanosomatids, but the mechanisms they use to
acquire flavins remain to be elucidated. We hypothesized that trypanosomatids require at least
one specialized transporter system to import riboflavin from their extracellular environment. In
the present work, we studied the role of riboflavin and its uptake in trypanosomatids. This led us
to identify and characterize a novel riboflavin transporter family in trypanosomatids, which we
named RibJ. Our results provide strong support for the notion that flavin transport and metabo-
lism may be effectively targeted by new therapeutics to be developed against trypanosomiasis.
Materials and methods
Parasites and culture media
Trypanosoma cruzi epimastigotes of the Y strain (DTU II) expressing GFP (Y-GFP, resistant to
G418) [31] and MJ Levin strain (DTU I) were cultivated at 28˚C in BHT medium [32], supple-
mented with 100 U/mL penicillin, 100 μg/mL streptomycin, 10% (v/v) heat-inactivated fetal
bovine serum (Natocor) and 20 μg/mL hemin (Sigma). The MJ Levin transgenic cell line was
cultivated in medium supplemented with 250 μg/mL G418 (Sigma) for selection. Cell lines
expressing GFP did not show differences with respect to the wild-type cells. Leishmania (Leish-
mania) mexicana (Costa Rica strain) promastigotes, Crithidia fasciculata (ATCC 11745) choa-
nomastigotes and Phytomonas Jma promastigotes were cultured in BHT medium, as described
for T. cruzi. Trypanosoma brucei (29–13 strain) procyclic forms were maintained in minimal
media consisting on Eagle’s minimum essential medium with L-glutamate (US Biological,
M3859) supplemented with 0.1 mM L-alanine, 0.1 mM L-asparagine, 0.1 mM L-aspartate, 0.1
mM L-glycine, 0.1 mM L-serine, 2 mM L-glutamine and 5 mM L-proline, 30 mM Na-Hepes
(pH 7.3), 26 mM NaHCO3, 2 mM sodium citrate, 27 mM glucose, with antibiotics and serum
similar to T. cruzi and 7.5 μg/mL hemin [33].
All cultures were maintained by periodically diluting (each 6–7 days) in fresh medium.
When indicated, parasites were cultured in the semi-defined medium SDM-79 [34] or in a
modified semi-defined medium with low riboflavin concentration (20 nM), named SDM-20,
both supplemented with antibiotics, 10% serum, 7.5 μg/mL hemin and 1 mM putrescine.
Plasmid constructions
Genomic DNA was extracted from T. cruzi, T. brucei or L. (L.) mexicana with UltraPure Phe-
nol (Invitrogen) according to the manufacturer instructions.
A fragment corresponding to TcRibJ (TcCLB.509885.70) was amplified using T. cruzi geno-
mic DNA as template, primers F-EcoRI-TcRibJ/R-HindIII-TcRibJ and platinum Taq DNA
polymerase (Invitrogen). The PCR product was purified, digested with EcoRI and HindIII
(New England Biolabs) and ligated using T4 DNA ligase (Invitrogen) into the T. cruzi expres-
sion vector pRIBOTEX [35] to yield pRIBOTEX-TcRibJ.
For heterologous complementation assays in E. coli, the recombinant expression vectors
pET24a-TcRibJ, pET24a-TbRibJ and pET24a-LmiRibJ were constructed harbouring TcRibJ,
TbRibJ (Tb927.5.470) and LmiRibJ (LmxM.08_29.2550) fragments from T. cruzi, T. brucei and
L. (L.) mexicana, respectively. A control vector was constructed using a non-related T. cruzi
permease, TcPAT12 [36,37]. All fragments were amplified from their respective genomic DNA
using high-fidelity PCR platinum Pfx DNA polymerase (Invitrogen) and specific primers: F-
TcRibJ-NdeI-6xHis/R-TcRib J-BamHI for T. cruzi, F-TbRibJ-NdeI-6xHis/R-TbRibJ-BamHI for
T. brucei and F-LmiRibJ-NdeI-6xHis/R-LmiRibJ-BamHI for L. (L.) mexicana. The products
were cloned by PCR cloning technique using Q5 high-fidelity DNA polymerase (New England
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Biolabs) and pET24a plasmid (Novagen) as template, according to the manufacturer
instructions.
All constructions were corroborated by sequencing. Primers used in this study are listed in
S1 Table.
Parasite transfection
T. cruzi MJ Levin strain was transfected with pRIBOTEX-TcRibJ and pRIBOTEX-GFP as fol-
lows: 108 epimastigote cells grown in BHT medium were harvested by centrifugation, washed
with PBS, and resuspended in 0.35 mL of electroporation buffer (PBS containing 0.5 mM
MgCl2 and 0.1 mM CaCl2). The cell suspension was mixed with 50 μg of plasmid DNA in 0.2
cm gap cuvettes (Bio-Rad Laboratories). The parasites were electroporated using a single pulse
of (400 V, 500 μF), showing a time constant of ~5 ms. Transfected parasites were cultured in
fresh BHT for 24 h and later G418 was added at 250 μg/mL. The MJ Levin strain has been
selected for these experiments because of its higher success rate in obtaining transformed
clones compared to the Y strain, in the conditions tested during this work.
Trypanosomatid proliferation assay
The effect of flavins or their analogs on parasites proliferation was evaluated through growth
curves. Stationary phase parasites were inoculated in fresh SDM-79 or SDM-20 media (basal
20 nM riboflavin) supplemented to a defined riboflavin concentration. Initial density for T.
cruzi Y-GFP, MJ Levin-GFP (referenced as wild-type) and MJ Levin-TcRibJ (referenced as
TcRibJ) was 107 parasite/mL, while initial density for T. brucei, L. (L.) mexicana, C. fasciculata
and Phytomonas Jma was 106 parasites/mL. Riboflavin, flavin mononucleotide (FMN) and fla-
vin adenine dinucleotide (FAD) were dissolved in water and the analogs lumiflavin, lumi-
chrome and roseoflavin (all from Sigma-Adrich) dissolved in DMSO. Then, flavins and
analogs were added to the culture media at the indicated concentrations. Parasites were daily
counted using a hemocytometer chamber. Proliferation was calculated as the percentage of
parasite counts relative to control condition values (flavin at 20 nM or without analogs) on the
fifth day. Day 5 was chosen because it is when all parasite cultures tested reach stationary
phase in control conditions (S1 Fig).
Riboflavin transport assay in trypanosomatids
The riboflavin uptake measurements were performed using a radiolabeled [3H]-riboflavin (6.2
Ci/mmol) (Movarek Biochemicals Inc.) tracer, adapted from arginine transport assays per-
formed by Canepa et al. [38] with slight modifications. Briefly, epimastigotes of T. cruzi, choa-
nomastigotes of C. fasciculata and promastigotes of L. mexicana and of Phytomonas Jma were
cultured in BHT, while T. brucei procyclic parasites were cultured in SDM-79, to late logarith-
mic phase. Then, they were harvested and resuspended in fresh media. The cultures were
maintained at 28˚C until mid-exponential growth, then parasites were harvested, washed three
times with PBS-2% glucose, and resuspended in the same buffer for starvation at 28˚C with
shaking for 3 h. Then, parasites were collected and resuspended in PBS-2% glucose, at a cell
density of 300–400 x 106 parasites/mL (30–40 x 106 parasites/tube), and kept at 37˚C for 15
min. The assay started after the addition of the radiolabeled riboflavin solution. Riboflavin
final concentrations and time points are indicated in each case. To stop the uptake assay, ali-
quots (0.1 mL) corresponding to each measured point, were placed in 1 mL of stop solution
(ice-cold 500 μM unlabeled riboflavin in PBS). Parasites were collected and washed three
times with stop solution. Cell pellets were counted for radioactivity in UltimaGold XR liq-
uid scintillation cocktail (Packard Instrument Co., Meridien CT, USA). The kinetic
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parameters (Vmax and apparent Km) were determined as described in “Kinetic parameters
calculation and statistical analysis” section.
Transport displacement assays were performed at 0.3 μM [3H]-riboflavin (concentration
near to the apparent Km value for riboflavin transport estimated in this work) adding unla-
beled flavins or analogs at 10- or 100-fold concentration excess.
To compare the transport activity between MJ Levin-TcRibJ and MJ Levin-GFP strains,
parasites were cultivated in SDM-20 fresh medium.
Bioinformatics analysis
The sequence of the riboflavin transporter Mch5/YOR306C of Saccharomyces cerevisiae [21]
was obtained from the Saccharomyces Genome Database (http://www.yeastgenome.org/) and
employed in the TriTryp database server (http://tritrypdb.org/tritrypdb/) to find similar pro-
teins from trypanosomatid genomes.
The Mch5p, TcRibJ, TbRibJ and LmiRibj multiple sequence alignment (MSA) was carried
out using the MUSCLE program from the EMBL-EBI server (http://www.ebi.ac.uk/Tools/
msa/muscle/). Putative N-glycosylation sites of Mch5p, TcRibJ, TbRibJ and LmiRibJ were
found using NetNGlyc 1.0 Server (http://www.cbs.dtu.dk/services/NetNGlyc/).
Putative riboflavin transporters similar to TcRibJ from parasites with complete or partially
assembled genome sequence were identified using a BLAST search in NCBI database (http://
www.ncbi.nlm.nih.gov/assembly) with the exception of Bodo saltans and Trypanoplasma bor-
reli draft genomes that have been deposited in the Sanger Institute database (http://www.
sanger.ac.uk/resources/downloads/protozoa/). The similarity between TcRibJ and other RibJ
was determined using ClustalW program with Geneious version 4.8.4 software (http://www.
geneious.com/). This program was also used to predict the putative transmembrane regions in
RibJ.
The maximum-likelihood tree was constructed with the MEGA6 free software, using a
ClustalW MSA of RibJ from kinetoplastids, using bootstrap support (500 pseudoreplicates)
and the Le and Gascuel model [39] without Gamma Distribution as the best evolutionary
model selected by the software. The accession numbers of all sequences are listed in S2 and S3
Tables.
The neighbor-joining tree was performed with MEGA6 free software (http://en.bio-soft.
net/tree/MEGA.html) according to the following pipeline: MSA of riboflavin transporters with
the ClustalW program; protein distance calculation with the JTT matrix and neighbor-joining
consensus tree construction with a bootstrap support (1000 pseudoreplicates); all bioinformat-
ics tools were used with default parameters. The tree was constructed using the amino acidic
sequences from mammalian (RFVT/SLC52), fungi (Mch5), nematodes (rft) and kinetoplastid
(RibJ) riboflavin transporter families. The results were visualized using iTOL server (http://
itol.embl.de/). The accession numbers of all sequences are provided in S4 Table.The pairwise
global alignment between TcRibJ and human RFVTs sequences, were performed with the soft-
ware EMBOSS Needle (http://www.ebi.ac.uk/Tools/psa/emboss_needle/). The accession num-
bers of all sequences are given in S5 Table.
Complementation growth assay in ΔribB E. coli
The ΔribB::cat E. coli strain (ΔribB), kindly provided by Garcı´a Angulo et al. [19], was used to
functionally characterize RibJ riboflavin transporters. ΔribB is unable to import [17] and syn-
thesize [19] riboflavin, and can only be cultured at high riboflavin concentrations. This strain,
also resistant to chloramphenicol, was cultured in LB medium at 37˚C in a shaker (250 rpm)
in the presence of the antibiotic and with excess of riboflavin (750 μM).
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The strain ΔribB was transformed using pET24a-TcRibJ, pET24a-TbRibJ, pET24a-LmiRibJ,
pET24d-TcPAT12 or an empty vector (pET24a). As a positive control the pET24a-RibM plas-
mid was included, which codes for the RibM riboflavin transporter from Streptomyces dava-
wensis and was kindly provided to us by Dr. Matthias Mack [18]. Selection was carried out on
LB agar plates supplemented with kanamycin (50 μg/mL) and excess of riboflavin.
For heterologous expression assays (in solid and liquid media), the ΔribB + pET24a, ΔribB
+ pET24a-RibM, ΔribB + pET24a-TcRibJ, ΔribB + pET24a-TbRibJ, ΔribB + pET24a-LmiRibJ
or ΔribB + pET24a-TcPAT12 strains were cultured overnight in LB broth with kanamycin
(50 μg/mL) and excess of riboflavin at 37˚C with shaking until the stationary phase. Two mL
from each culture were centrifuged at 5,000 rpm, pellets were washed twice with PBS and
resuspended in fresh LB with kanamycin added, but no riboflavin. Ten μL aliquots (OD600 =
0.01) were used to inoculate LB-agar plates or 2 mL of liquid LB, in both cases supplemented
with kanamycin (50 μg/mL), IPTG (0.1 mM) and the indicated riboflavin concentrations for
each assay. Cultures were incubated at 37˚C for 24 h. Plate images were taken and liquid LB
medium cultures OD600 values were recorded.
Riboflavin transport assay in ΔribB E. coli
The ΔribB + pET24a, ΔribB + pET24a-RibM, ΔribB + pET24a-TcRibJ and ΔribB + pET24a-
TbRibJ strains were cultured overnight in LB medium with kanamycin (50 μg/mL) and excess
of riboflavin. Fresh LB medium (kanamycin 50 μg/mL, IPTG 0.4 mM) was inoculated with
these bacteria at an initial OD600 = 0.01, and incubated at 28˚C in the absence of riboflavin, to
deplete the intracellular vitamin, until they reached the mid-exponential growth phase (OD600
= 0.8–1.2). Cells were harvested, washed three times with PBS- 2% glucose (transport buffer),
and resuspended at a final OD600 = 5 in the same buffer. The cell suspension was pre-incubated
in transport buffer for 15 min at 37˚C and the uptake assay started when the [3H]-riboflavin
solution was added (final concentration 2 μM). Aliquots of 0.2 mL were taken at indicated
times and placed in 1 mL of stop solution (ice-cold 500 μM nonradioactive riboflavin in PBS)
[19]. Cells were centrifuged at 13,000 rpm for 1 min and washed three times with stop solution.
Bacterial pellets were counted for radioactivity in UltimaGold XR liquid scintillation cocktail.
The displacement assay was performed using the same strains in the presence of 0.3 μM
radiolabeled riboflavin and the nonradioactive competitors at 3 μM and 30 μM.
In all cases, the value obtained with ΔribB + pET24a, which corresponds to unspecific bind-
ing, was subtracted from the other measurements.
Antibiotics susceptibility assay
This assay was performed to corroborate that the permeability of ΔribB E. coli was not affected
by the expression of heterologous riboflavin transporters. Transformed E. coli ΔribB strains
were cultivated in liquid LB with excess of riboflavin (750 μM) and bactericidal compounds
(0–40 μg/mL nalidixic acid or 0–250 μg/mL acriflavine), then growth IC50 values were
determined.
T. cruzi in vitro metacyclogenesis assay
The in vitro differentiation assay was performed as previously described [40]. Briefly, 7-day-
old T. cruzi epimastigotes (Y-GFP strain) cultured in SDM-20 were harvested and incubated
for 2 h at 37˚C in triatomine artificial urine (TAU) medium. Next, parasites were diluted in
TAU3AAG medium (TAU supplemented with 10 mM L-proline, 50 mM L-sodium glutamate,
2 mM L- sodium aspartate and 10 mM D-glucose) with the addition of 0–300 nM riboflavin,
FMN or FAD, or 10 μM analogs. Parasites were cultured at 28˚C for 48 h. The epimastigotes
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and differentiated metacyclic trypomastigotes (MT) mix was harvested by centrifugation at
600 × g for 15 min and resuspended in 0.5 mL of fresh human serum, which selectively lyses
epimastigotes [41]. MT, easily seen by light microscopy, were quantified using a hemocytome-
ter chamber.
T. cruzi in vitro infection assay
The in vitro infection assay was performed following protocols previously described [40].
Briefly, T. cruzi tissue culture trypomastigotes (TCT) (Y-GFP strain), obtained from VERO
cells, were pre-treated with 10 μM riboflavin analogs at 37˚C for 2 h. Subsequently, monolayers
of H9C2 cardiomyoblasts, which had been grown in DMEM-10% fetal bovine serum (FBS) in
24-well plates containing glass coverslips, were infected with the TCT using 10 parasites per
cell (MOI 10:1). The co-cultures were maintained in the presence of 10 μM riboflavin analogs
at 37˚C for 12 h allowing the cardiomyoblast infection. Unbound TCTs were removed by
washing with fresh DMEM, and infected mammalian monolayers were incubated in DMEM-
3% FBS, 10 μM riboflavin analogs, at 37˚C for 48 h. For these assays, riboflavin analogs were
dissolved in a DMSO/DMEM solution (1:100 v/v). Then, samples were fixed with 10% parafor-
maldehyde; the actin cytoskeleton of the H9C2 cells was stained with TRITC-phalloidin (Invi-
trogen) and parasites were directly visualized due to the stable expression of GFP [40]. Finally,
cell invasion (expressed as percentage of infected host cell) and amastigotes proliferation
(number of amastigotes per cell) were quantified using confocal microscopy (FV1000 Confocal
Olympus microscope).
Kinetic parameters calculation and statistical analysis
Standard procedures were used to determine kinetic parameters. The apparent Km and Vmax val-
ues were obtained by nonlinear regression fit of the Michaelis-Menten equation to the data. Sta-
tistics, curve fitting, Vmax and apparent Km were calculated using the GraphPad Prism 6 software.
Each experiment was carried out at least three times. Groups were analyzed using one-way
ANOVA test followed by a post-hoc Tukey’s multiple comparison test (significance cut-off
value P = 0.05). The infectivity and amastigote replication assays were analyzed using a non-
parametric test (Kruskal-Wallis) and compared against the control condition through Dunn’s
test (significance cut-off value P = 0.05).
The correlation analysis was performed between the maximum density values reached with
riboflavin-supplemented media from each parasite and the apparent Km values for riboflavin
uptake. The correlation was estimated using the Pearson coefficient (significance cut-off value
P = 0.05, two-tailed). A linear regression was represented with confidence intervals at 95%.
Ethics statement
All parasites used during this work are laboratory strains. T. cruzi Y-GFP, Phytomonas Jma
and C. fasciculata (ATCC 11745) strains were previously reported by our group [40,42,43]. T.
cruzi MJ Levin strain was provided by Dr. Claudio Pereira [44]. T. brucei (29–13 strain) and L.
(L.) mexicana (Costa Rica strain) were kindly provided by Dr. Guillermo Alonso [45] and Dr.
Carlos Labriola [32], respectively.
Results
Effects of flavins on proliferation of trypanosomatids
As trypanosomatids lack biosynthetic enzymes for B-vitamins, we tested the effects that extra-
cellular flavins exert on proliferation of trypanosomatids. T. cruzi epimastigotes moderately
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proliferated at low concentration (20 nM) of riboflavin or its derivatives FMN and FAD.
Higher concentrations of flavins (< 300 nM) significantly increased the T. cruzi proliferation
(74.3 ± 3.6% for riboflavin, 32 ± 3.2% for FMN and 32.8 ± 7.7% for FAD, compared to the con-
trol); concentrations higher than 300 nM of riboflavin and FMN had a negative proliferation
effect (Fig 1A). Flavins also showed a stimulatory effect on proliferation of T. brucei procyclic
parasites, C. fasciculata choanomastigotes and promastigotes of L. (L.) mexicana and Phytomo-
nas Jma, exhibiting slight differences in doses-response profiles (S2 Fig).
Fig 1. Flavins and chemical analogs are incorporated into T. cruzi epimastigotes and affect their proliferation with opposite effects. Chemical
structures of riboflavin, FMN and FAD, and their analogs roseoflavin, lumiflavin and lumichrome are shown in A and B top panels. A and B bottom panels: T.
cruzi Y strain epimastigotes were maintained at 28˚C until stationary phase, then washed and incubated in fresh medium with the indicated compound
concentrations: (A) flavins and (B) chemical analogs plus 300 nM riboflavin. Parasites were counted daily. T. cruzi proliferation (%) was calculated at the
indicated round using fifth day-counts and control conditions -(A) 20 nM flavins or (B) 0 μM analogs- as references (100%). Log-phase Y strain
epimastigotes grown in BHT-10% FBS were harvested, washed, resuspended in PBS-2% glucose and incubated at 37˚C. (C) Riboflavin uptake velocity
was calculated at 0–5 μM final substrate concentration. Aliquots were sampled at 0 and 5 min after the addition of radioactive material. Displacement
assays were performed at 0.3 μM radioactive riboflavin mix (Ctrl: control, 100%) and 3–30 μM of (D) unlabeled flavins (RF, FMN or FAD) or (E) unlabeled
analogs (RoF: roseoflavin, n = 3; LF: lumiflavin, n = 4; or LC: lumichrome; n = 4). Values are expressed as mean ± SD. Statistical analysis was performed by
one way ANOVA test followed by a post-hoc Tukey’s multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.005).
https://doi.org/10.1371/journal.pntd.0005513.g001
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On the other hand, the riboflavin analogs roseoflavin [46], lumiflavin and lumichrome [47]
affected trypanosomatid proliferation rates. While lumiflavin and lumichrome (at 10 μM)
showed effects on T. cruzi in the third round of culture (32.8 ± 6.3% and 28.5 ± 2.5% lower
than the control, respectively), roseoflavin treatment resulted in a marked reduction of parasite
proliferation in the first round of culture (21.4 ± 0.8% lower than control) (Fig 1B and S3 Fig).
These results suggest that trypanosomatids incorporate extracellular flavins and that one
could interfere with flavin uptake and/or the downstream metabolism to affect proliferation of
the parasites.
Riboflavin uptake in trypanosomatids
A [3H]-riboflavin transport assay was performed to measure its uptake in trypanosomatids. T.
cruzi, as well as T. brucei, L. (L.) mexicana, C. fasciculata and Phytomonas Jma showed ribofla-
vin uptake following Michaelis-Menten kinetics, with a maximal velocity at 1–2 μM of ribofla-
vin and apparent Km values in the submicromolar range, indicative for the involvement of a
high-affinity transporter (Fig 1C, S4 Fig and Table 1). Riboflavin derivatives were efficient
competitors of the [3H]-riboflavin uptake in T. cruzi epimastigotes, with FMN being more
effective than FAD (Fig 1D). On the other hand, lumichrome showed mild competitive effects,
while roseoflavin and lumiflavin significantly reduced 70 to 90% and 35 to 65% the [3H]-ribo-
flavin uptake, respectively (Fig 1E).
RibJ: A novel family of riboflavin transporters in trypanosomatids
As a first approach for in silico studies, sequences of previously characterized transporters
from bacteria, Saccharomyces cerevisiae, Caenorhabditis elegans and mammals [12–14,16–21]
were used as queries in BLAST searches against the T. cruzi genome. Only the riboflavin trans-
porter Mch5p from S. cerevisiae showed a hit with low identity (21%) and similarity (37%) val-
ues. The gene alleles, TcCLB.509885.70 and TcCLB.508397.70, are encoded in chromosome
28-S and 28-P, respectively. This putative riboflavin transporter, which we named here TcRibJ,
is 472 amino acids long and contains three possible N-glycosylation sites (N108, N236 and
N431) and 12 hydrophobic regions, probably corresponding to 12 transmembrane segments,
which are also present in Mch5p (Fig 2A).
The TcRibJ sequence was used as query to find homologs in T. brucei and L. (L.) mexicana,
finding ortholog genes that code for proteins similar to TcRibJ: TbRibJ (62.2% identity) and
LmiRibJ (48.9% identity). The three RibJ members showed at the N-terminal region a Major
Facilitator Superfamily domain (MFS domains), found in small solute transporters [48] (Fig
2A and S2 Table).
RibJ orthologs, exhibiting an MFS domain and 12 predicted transmembrane segments,
were retrieved from totally or partially assembled genomes from representatives of the Metaki-
netoplastina subclass (S2 and S3 Tables, respectively). RibJ members were even found in phy-
logenetically distant taxa from T. cruzi, as the free-living kinetoplastid Bodo saltans (order
Eubodonida) and the fish endoparasite Trypanoplasma borreli (order Parabodonida), while
the Perkinsela sp. genome (subclass Prokinetoplastina) did not show any recognizable homo-
log. Using all these identified sequences, a phylogenetic maximum-likelihood tree was con-
structed (S5 Fig) with a topology in accordance with the currently accepted Kinetoplastea
phylogeny [49]. Therefore, it is likely that the RibJ transporter family has a common origin in
Metakinetoplastids, which diversified reminiscently of the speciation process, with Phytomo-
nas spp. RibJ being the most distant transporter in the order.
To complete the phylogenetic analysis of eukaryotic riboflavin transporters, the amino acid
sequences from the human riboflavin transporter (RFVT1/SLC52A1) [12], C. elegans rft-1 [13]
RibJ: A novel trypanosomatid riboflavin transporter
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and yeast Mch5p [21] were used as queries in a BLAST search in the NCBI database. Represen-
tative sequences comprising the mammalian, nematodal and fungal datasets (S4 Table) and,
including the kinetoplastid RibJ transporters, were used to construct a neighbor-joining tree
(Fig 2B). Riboflavin transporter members cluster in three distinct major groups, revealing that
RibJ constitutes a novel family, the first one identified in protists and the third in eukaryotes,
distant from the RFVT/SLC52 family and more related to the Mch5p family (97% bootstrap
support).
Functional characterization of RibJ members
To evaluate the functionality of RibJ as a riboflavin transporter we designed an experiment of
heterologous expression to restore growth of a riboflavin auxotrophic bacterium. The ribB E.
coli null mutant strain (ΔribB) [19] was transformed with expression vectors carrying either
the TcRibJ, TbRibJ or LmiRibJ gene. An empty vector and one harbouring the TcPAT12 gene
(the polyamine transporter of T. cruzi) [36,37] were included as negative controls, and a plas-
mid encoding the RibM riboflavin transporter from Streptomyces davawensis [18] as a positive
control. All transformants grew when plated on LB medium plus an excess (750 μM) of ribofla-
vin, while only ΔribB expressing RibM could grow when no riboflavin was supplemented (Fig
3A), since RibM incorporates riboflavin traces present in the LB medium [19]. When ribofla-
vin was added in a restrictive concentration (5 μM), TcRibJ and TbRibJ also supported ΔribB
growth (Fig 3A). Similar results were obtained in liquid LB medium assays, where TcRibJ and
TbRibJ restored the growth capacity in the presence of riboflavin, and also FMN and FAD,
although at higher concentrations (Fig 3B). These findings confirm that RibJ proteins possess
flavin transporter activity in vivo. In all conditions, negative controls (TcPAT12 or empty vec-
tor) failed in restoring ΔribB growth. Strikingly, despite the similarities with the other RibJ,
LmiRibJ was unable to transport riboflavin in this heterologous system (Fig 3A and 3B).
TcRibJ and TbRibJ heterologous expression allowed ΔribB strains to incorporate [3H]-ribo-
flavin with a linear time-dependent velocity for the first 60 min at 4.1 and 7.3 fmol/OD600.min,
respectively (Fig 3C). The transport specificity was confirmed by displacement assays per-
formed at 10- or 100-fold unlabeled riboflavin excess (Fig 3D). To rule out membrane perme-
ability alterations or unspecific transport due to the heterologous expression of membrane
proteins, an antibiotics susceptibility assay was performed. IC50 values for nalidixic acid and
acriflavine in E. coli ΔribB strains (0.47–0.76 μg/mL and 21.3–29.1 μg/mL, respectively) (S6
Fig) were similar to those reported in the literature [50,51], indicating that the flavin uptake
measured in these strains was the result of specific flavin transporter activity.
TcRibJ is a flavin transporter in T. cruzi
To confirm the RibJ functionality in trypanosomatids, we transformed T. cruzi epimastigotes
with TcRibJ to generate an over-expressing strain (TcRibJ). This strain showed increased pro-
liferation rates in the presence of low concentrations (20 nM) of any flavin (riboflavin, FMN
Table 1. Riboflavin apparent Km and Vmax uptake parameters measured in trypanosomatids.
Trypanosomatid Km (μM) Vmax (fmol/107 parasites min)
T. cruzi 0.22 ± 0.08 67.09 ± 5.03
T. brucei 0.39 ± 0.08 38.00 ± 2.10
L. (L.) mexicana 0.07 ± 0.03 42.80 ± 3.20
C. fasciculata 0.14 ± 0.04 108.10 ± 6.30
Phytomonas Jma 0.35 ± 0.11 12.20 ± 1.00
https://doi.org/10.1371/journal.pntd.0005513.t001
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Fig 2. RibJ is a novel family of riboflavin transporters characteristic of trypanosomatids. (A) Multiple sequence alignment between Mch5p (S.
cerevisiae), TcRibJ, TbRibJ and LmiRibJ using MUSCLE program. Red boxes: putative transmembrane domains; light blue box: MFS domain; green boxes:
the Asn in N-glycosylation context. Black, gray and violet backgrounds represent 100%, 80%, and 60% conservation within similarity groups, respectively.
RibJ: A novel trypanosomatid riboflavin transporter
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or FAD) (Fig 4A), higher sensibility to riboflavin analogs (Fig 4B) and increased riboflavin
uptake (1.5 ± 0.4-fold) (Fig 4C), compared to the wild-type strain. These results confirm that
TcRibJ is a functional flavin transporter in T. cruzi, and that its activity affects proliferation of
epimastigotes.
(B) A Neighbor-joining tree (1000 pseudoreplicates) was constructed using the amino acid sequences from riboflavin transporters: 22 mammalian (RFVT/
SLC52, light green), 15 fungal (Mch5p, yellow), 5 nematodal (rft, dark green) and 16 RibJ belonging to subclass Metakinetoplastids (light blue, and inside,
trypanosomatids group in violet). The blue arrows indicate RibJ from T. cruzi, T. brucei and L. (L.) mexicana, and the human and S. cerevisiae riboflavin
transporters.
https://doi.org/10.1371/journal.pntd.0005513.g002
Fig 3. TcRibJ and TbRibJ display flavin transport activity in E. coli. The E. coli ΔribB strain was transformed
with expression plasmids coding for either RibM, TcRibJ, TbRibJ, LmiRibJ or TcPAT12, or with an empty vector.
Strains were (A) plated on LB agar (left: strain plating scheme) with the addition of 0, 5 or 750 μM riboflavin (RF) or
(B) cultured at 37˚C for 24 h in liquid LB supplemented with 0.02–100 μM FMN or FAD, or 0.02–20 μM riboflavin.
(C) [3H]-riboflavin uptake (2 μM) was measured from 0 to 180 min in bacteria expressing RibM, TcRibJ or TbRibJ or
containing an empty vector. (D) Displacement assays performed with 0.3 μM [3H]-riboflavin in the absence of
competitors (Ctrl: control) or in the presence of 3–30 μM of unlabelled riboflavin; aliquots were sampled at 0 and
120 min after the addition of the radioactive material. Values are expressed as mean ± SD. Statistical analysis was
performed by one way ANOVA test followed by a post-hoc Tukey’s multiple comparison test (*P < 0.05,
**P < 0.01, ***P < 0.005).
https://doi.org/10.1371/journal.pntd.0005513.g003
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Flavins play an important role in T. cruzi life cycle
To get a broader view of the role that flavins play in trypanosomatid physiology, we tested how
they affect T. cruzi metacyclogenesis (Fig 5A). When flavins were added to the differentiation
medium (TAU3AAG), a significant higher percentage of epimastigotes differentiated to meta-
cyclic trypomastigotes (MT) compared to control conditions, while all flavin analogs produced
a dramatic reduction of MT counts (Fig 5B and 5C). Strikingly, roseoflavin completely abol-
ished MT counts (Fig 5C); however, it still remains to be determined whether this effect is a
consequence of affecting (i) the viability of epimastigotes in the process of metacyclogenesis,
(ii) directly metacyclogenesis and/or (iii) MT viability.
Once inside the mammalian host, cellular invasion and intracellular replication are essential
events for a successful T. cruzi infection [40]. Hence, we evaluated the effect of flavins on these
processes in an in vitro infection model (Fig 5D). Flavin analogs produced a mild reduction in
infected host cell counts (Fig 5E) and reduced amastigote intracellular proliferation, with sta-
tistically significance for roseoflavin (11.4 ± 0.3 vs 2.2 ± 2.3 amastigotes per infected cell for
control and roseoflavin treatment, respectively) (Fig 5F).
Taken together, these results strongly suggest that flavins are necessary for metacyclogenesis
and amastigote proliferation in T. cruzi, and that interfering with riboflavin transport and/or
downstream metabolism may impair these processes.
Fig 4. TcRibJ functions as flavin transport in vivo in T. cruzi. Epimastigotes transfected with
pRIBOTEX-GFP (wt) or pRIBOTEX-TcRibJ (TcRibJ) were incubated in fresh SDM-20-10% FBS in the
presence of (A) 20 nM riboflavin (RF), FMN or FAD, or (B) roseoflavin (RoF), lumiflavin (LF), or lumichrome
(LC), at the indicated concentrations. Parasites were counted daily using a hemocytometer chamber. T. cruzi
proliferation (%) was calculated at the third culture round, where the control condition (20 nM flavin) was
referenced as 100%. (C) [3H]-riboflavin (100 nM) uptake measurements in control and over-expressing
TcRibJ epimastigotes. Values are expressed as mean ± SD. (A-B) Statistical analysis was performed by a
two-tailed unpaired t test (*P < 0.05, **P < 0.01, ***P < 0.005).
https://doi.org/10.1371/journal.pntd.0005513.g004
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Discussion
To date, only few studies on B-vitamins transporters have been reported for trypanosomatids:
(i) folic acid transporters were molecularly characterized in Leishmania spp. [52]; (ii) myo-ino-
sitol transporter genes were identified in Leishmania spp. and T. brucei, while a biochemical
characterization was performed of this transporter in T. cruzi [53]; and (iii) the choline uptake
was biochemically studied in Leishmania sp. and T. brucei, but choline transporter genes still
remain to be identified [54,55].
Our results demonstrate that extracellular flavins are naturally incorporated in trypanoso-
matids, affecting their proliferation (Figs 1 and S2–S4). In all trypanosomatids assessed, ribo-
flavin uptake is mediated by high-affinity transporters, presenting Km values in the nanomolar
range (Fig 1 and Table 1). In contrast, other microorganisms show low-affinity riboflavin
transport, for example, S. cerevisiae and Ashbya gossypii exhibits Km in the micromolar order
with values of 17 and 40 μM, respectively [21,56]. High-affinity transporters are commonly
found in trypanosomatids and it is assumed as an evolutionary adaptation to their restricted
nutritional environments [57]. Their invertebrate vectors obtain riboflavin from the diet and
their microbiota, and provide a vitamin restrictive environment for parasites [58,59]. Even
Fig 5. Flavins stimulate while analogs retard progression through T. cruzi life cycle. (A) In vitro metacyclogenesis assay scheme (for
more details, see ‘Material and methods‘ section). Percentage of MT obtained in differentiation media (TAU3AAG) supplemented with (B)
flavins (riboflavin: RF, FMN or FAD), or (C) chemical analogs (roseoflavin: RoF, lumiflavin: LF, or lumichrome: LC), at the indicated
concentrations at 48 h. (D) In vitro infection assay scheme (for more details, see ‘Material and methods‘ section). Effect of 10 μM analogs on
(E) cellular invasion at 48 h, expressed as percentage of H9C2 host cells infected with T. cruzi Y-GFP (*400 cells counted) or (F)
amastigote proliferation at 48 h, expressed as number of T. cruzi Y-GFP amastigotes per infected H9C2 host cell. Values are expressed as
mean ± SD. Statistical analysis was performed by a Kruskal-Wallis non-parametric test followed by a post-hoc Dunn’s multiple comparison
test (*P < 0.05, **P < 0.01, ***P < 0.005).
https://doi.org/10.1371/journal.pntd.0005513.g005
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more, parasites in mammalian hosts are exposed to very low riboflavin concentration, within
the nanomolar range in human plasma [60] and attomolar intracellular concentrations [61].
On the other hand, Phytomonas spp. inhabit a millimolar flavin environment once inside their
host plants [62], developing a particular energy metabolism that relies on flavoenzymes [63].
In all cases, trypanosomatids seems to be dependent on effective riboflavin uptake.
While the proliferation of T. cruzi epimastigotes, T. brucei procyclic forms and C. fasciculata
choanomastigotes was strongly promoted by riboflavin, the proliferation of L. (L.) mexicana
and Phytomonas Jma promastigotes was slightly stimulated by it (Figs 1 and S2). These differ-
ences found on proliferation inversely correlate with their corresponding transport affinity (S7
Fig, P< 0.05). Thus, parasites with less efficient riboflavin uptake present higher proliferation
when riboflavin is supplemented in the media. Contrarily, the moderate-proliferative parasites
upon riboflavin addition exhibit higher uptake affinities. This could suggest that there exists
regulatory mechanisms acting on riboflavin transport to prevent flavin accumulation in high
levels. In this sense, it was reported that flavin excess inhibit the expression of several genes
associated with riboflavin obtaining in bacteria [64,65]; also, regulatory mechanisms by nutri-
ents availability have been reported in several trypanosomatids [66]. Interestingly, Phytomonas
Jma is out of this correlation (S7 Fig), and the reason that may explain this is the high flavin
concentrations in its niche [62].
At certain extracellular flavin concentrations, a negative effect on trypanosomatid prolifera-
tion is produced (Figs 1A and S2), as similarly described for vitamins B12 (cobalamin) and B3
(nicotinamide) [67–69]. Previous reports show that an oxidative redox environment promotes
the T. cruzi epimastigotes proliferation by activating the Calcium/calmodulin-dependent pro-
tein kinase II (CaMKII) pathway, while in a reductive environment its proliferation is arrested
[70,71]. Thus, it is possible that some highly flavin enriched media (e.g. 600 nM riboflavin for T.
cruzi, Fig 1A) favors a reductive environment for the parasites, impairing trypanosomatid pro-
liferation. However, we cannot exclude another mechanisms such as direct or indirect effects at
gene expression levels produced by riboflavin, as reported in bacteria and mammalian cells
[65,72]. Interestingly, S2 Fig also shows that high flavin concentration in some cases still pro-
duced a positive stimulus on proliferation in T. brucei, L. (L.) mexicana or C. fasciculata (eg. 600
nM FAD for T. brucei, 600 nM riboflavin for L. mexicana and 600 nM FMN for C. fasciculata).
A possibility is that beyond certain threshold levels, there are onsets of active mechanisms con-
trolling the intracellular flavin concentrations, for example by flavin exporters. The existence of
such flavin-exporting activities have already been described for bacteria and mammals [18,73–
75]. However, the existence of flavin exporters in trypanosomatids remains unknown to date.
We have identified the novel family of riboflavin transporters RibJ, which is distinct and
distant from the two riboflavin transporters families previously described in eukaryotes, and
the first riboflavin transporter reported for protists (Fig 2). Since trypanosomatid parasites fre-
quently have redundant transport activities to guarantee supply from different nutritional
environments, as described for other compounds (amino acids, glucose, etc.) [38,76–80], we
cannot exclude the presence of additional yet unidentified riboflavin transporters. T. cruzi and
T. brucei RibJ members were functionally validated in vivo as flavin transporters using a heter-
ologous expression assay (Fig 3) and in a homologous over-expression system in T. cruzi epi-
mastigotes (Fig 4). Although L. (L.) mexicana transports riboflavin with the highest affinity
compared with the other parasites analyzed in this work, we could not confirm the LmiRibJ
functionality by the heterologous complementation assay. One possible explanation is that
LmjRibJ presents low or null expression levels or it does not adopt a functional conformation
in the E. coli system (Fig 2A).
Roseoflavin, lumiflavin and lumichrome inhibit riboflavin transport in some bacteria, S.
cerevisiae and mammalian cells [12,13,16–18,21]. In this work, the three riboflavin analogs
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showed different effects on the parasites, with T. cruzi riboflavin uptake and proliferation most
affected by roseoflavin (Figs 1 and S3). The differences between the effects by the three analogs
may be explained by their chemical structures (Fig 1A and 1B, top panel), where the high sim-
ilarity between roseoflavin and riboflavin (only one substitution in the isoalloxazine ring) may
enable this analog to mimic better the natural ligand. Additionally, roseoflavin presents antibi-
otic activity [65].
Human hepatocytes import roseoflavin and convert it by riboflavin kinase (EC 2.7.1.26)
and FAD synthetase (EC 2.7.7.2) to Ro-FMN (roseoflavin mononucleotide) and Ro-FAD
(roseoflavin adenine dinucleotide) analogs, and bind to intracellular flavoproteins, reducing or
abolishing their function [46], impairing cell viability [65]. Recently, putative genes for ribofla-
vin kinase (TcCLB.510741.80 and Tb09.211.3420) and FAD synthetase (TcCLB.508241.60)
have been identified in T. cruzi and T. brucei [30,81]. Similarly to hepatocytes, trypanosoma-
tids might import and convert roseoflavin to Ro-toxic analogs, impairing the flavin-related cel-
lular metabolic processes and, ultimately, replication (Figs 1B, S3 and 5F). It is worth
mentioning that flavoproteins has been proposed as targets for anti-infective strategies,
reviewed in [82], including proteins related to the anti-oxidant systems dihydrolipoamide
dehydrogenase (LipDH) and trypanothione reductase (TR). Several inhibitors have been suc-
cessfully found for both flavoproteins, some of which show trypanocidal activity. In fact,
LipDH is supposed to mediate at least partially the trypanocidal effect of nifurtimox and other
nitrofurans [82]. Thus, effective T. cruzi riboflavin transport inhibition could eventually result
in a depletion/reduction of its flavoenzyme pool, comprising LipDH and TR, and could lead–
per se or in combination with other drugs–to effective parasite death.
We have shown that limiting availability to flavins affects metacyclogenesis (Fig 5B and
5C), a critical event in T. cruzi life cycle progression. Although the underlying molecular
mechanisms in metacyclogenesis still remains unclear, antioxidants seem to be intimately
involved in the epimastigote-MT cellular stage switch [70]. A proteomic analysis of metacyclo-
genesis has revealed increased levels of proteins related to anti-oxidant systems including
LipDH [83]. It is possible that flavin restriction leads to a limited production of active flavoen-
zymes involved in anti-oxidant systems, and consequently to metacyclogenesis impairment as
seen in Fig 5B and 5C.
To finish, it is noteworthy that TcRibJ shows significant differences with the mammalian
RFVT/SLC52 family: (i) they share very low sequence identity and similarity values (18.1–
19.0% and 28,9–30,8%, respectively, S5 Table); (ii) only RibJ present MFS domains; (iii) they
show a different number of predicted transmembrane segments (12 for TcRibJ and 10–11 for
RFVTs, Fig 2A) [12]; and (iv) RFVTs seem to be less sensitive to riboflavin derivatives and ana-
logs than TcRibJ as they required more than 200-fold excess concentration of such competitor
compounds than the transporters of epimastigotes (see reference [84,85] and Fig 1D and 1E).
These differences, in addition to the results presented here that indicate the essentiality of
riboflavin for T. cruzi survival and life cycle progression, pose TcRibJ as a potential therapeutic
target against Chagas disease.
Supporting information
S1 Fig. Trypanosomatid growth curves in control conditions. Parasites were grown until sta-
tionary phase, then washed and incubated in fresh SDM-20–10% FBS with the addition of 20
nM riboflavin. Cell density was quantified at days 3, 5 and 8.
(TIF)
S2 Fig. Flavins promote the in vitro proliferation of trypanosomatids. Stationary phase try-
panosomatids were washed and incubated in fresh SDM-20–10% FBS with the addition of
RibJ: A novel trypanosomatid riboflavin transporter
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005513 April 13, 2017 16 / 22
different amounts of flavins (riboflavin: RF, FMN, or FAD). (A) T. brucei procyclic forms, (B)
L. (L.) mexicana promastigotes, (C) C. fasciculata choanomastigotes and (D) Phytomonas Jma
promastigotes were assayed. Trypanosomatid proliferation (%) was calculated counting para-
sites at the fifth day using control conditions (20 nM flavins) as reference (100%). Values are
expressed as mean ± SD. Statistical analysis was performed by one way ANOVA test followed
by a post-hoc Tukey’s multiple comparison test (P< 0.05, P < 0.01, P < 0.005).
(TIF)
S3 Fig. Riboflavin analogs inhibit in vitro proliferation of trypanosomatids. Parasites were
maintained at 28˚C in SDM-79 supplemented with 10% FBS. In the stationary phase, cells
were washed with PBS and incubated in fresh SDM-79 supplemented with 10% FBS with the
addition of analogs at 10 μM: (A) roseoflavin (RoF), (B) lumiflavin (LF) and (C) lumichrome
(LC). Parasites were counted daily. Trypanosomatid proliferation (%) was calculated at the
indicated round using fifth day-counts and using control condition without analog as refer-
ence (100%). Results obtained for T. cruzi were included for comparison. ND: differences not
detected. Values are expressed as mean ± SD. Statistical analysis was performed by one way
ANOVA test followed by a post-hoc Tukey’s multiple comparison test (P < 0.05, P< 0.01,
P< 0.005).
(TIF)
S4 Fig. Riboflavin uptake apparent Km and Vmax parameters determinations in trypanoso-
matids. (A) T. brucei procyclic trypomastigotes, (B) L. (L.) mexicana promastigotes, (C) C. fas-
ciculata choanamastigotes and (D) Phytomonas Jma promastigotes were used for the
biochemical measurements. Parasites were grown in BHT media supplemented with FBS 10%,
with the exception of T. brucei which was cultured in SDM-79 (FBS 10%), and cultured at
28˚C until late log-phase. Cells were harvested, washed and resuspended in PBS- 2% glucose.
The transport assays were performed in the range of 0–5 μM riboflavin (RF) final concentra-
tion. Aliquots were sampled at 0 and 5 min to calculate initial velocity. Values are expressed as
mean ± SD. The apparent Km and Vmax values were obtained by nonlinear regression fit of the
data to the Michaelis-Menten equation.
(TIF)
S5 Fig. Maximum likelihood RibJ phylogenetic tree from Kinetoplastea. The tree was con-
structed using RibJ amino acid sequences from 37 trypanosomatids, 1 eubodonid and 1 para-
bodonid and Le and Gascuel model (-Ln = 8970.5397). Blue arrows indicate the RibJ of T.
cruzi, T. brucei and L. (L.) mexicana studied during this work.
(TIF)
S6 Fig. Heterologous expression of RibJ transporters does not alter membrane integrity. E.
coli ΔribB strain transformed with an empty vector or plasmids carrying RibM, TcRibJ, TbRibJ
or LmiRibJ were cultured in liquid LB with riboflavin excess at 37˚C for 16 h with the addition
of bactericidal compounds: (A) nalidixic acid (0, 2.5, 5, 10, 20 and 40 μg/mL), and (B) acrifla-
vine (0, 10, 25, 50, 100 and 250 μg/mL). Values are expressed as mean ± SD.
(TIF)
S7 Fig. Correlation analysis for maximum density and apparent Km values for riboflavin
uptake. The relative growth for each trypanosomatid (calculated as the maximum parasite
count in riboflavin supplemented medium relative to control conditions) is plotted against its
corresponding apparent Km value. In this analysis, the relative growth obtained for the animal
parasites (red) correlates with its transport properties (Pearson coefficient = 0.955, P< 0.05,
represented as a grey area between the dotted lines). The plant parasite Phytomonas Jma
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(green) does not present this correlation.
(TIF)
S1 Table. Primers designed to clone putative riboflavin transporters of T. cruzi, T. brucei
and L. (L.) mexicana.
(PDF)
S2 Table. Identification of potential RibJ transporters in trypanosomatids with totally
assembled genomes.
(PDF)
S3 Table. Identification of potential RibJ transporters in kinetoplastids with partially
assembled genomes.
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